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Objective: The lack of pro-opiomelanocortin (POMC)-derived melanocortin peptides results in hypoadrenalism and severe obesity in both
humans and rodents that is treatable with synthetic melanocortins. However, there are signiﬁcant differences in POMC processing between
humans and rodents, and little is known about the relative physiological importance of POMC products in the human brain. The aim of this study
was to determine which POMC-derived peptides are present in the human brain, to establish their relative concentrations, and to test if their
production is dynamically regulated.
Methods: We analysed both fresh post-mortem human hypothalamic tissue and hypothalamic neurons derived from human pluripotent stem
cells (hPSCs) using liquid chromatography tandem mass spectrometry (LC-MS/MS) to determine the sequence and quantify the production of
hypothalamic neuropeptides, including those derived from POMC.
Results: In both in vitro and in vivo hypothalamic cells, LC-MS/MS revealed the sequence of hundreds of neuropeptides as a resource for the
ﬁeld. Although the existence of b-melanocyte stimulating hormone (MSH) is controversial, we found that both this peptide and desacetyl a-MSH
(d-a-MSH) were produced in considerable excess of acetylated a-MSH. In hPSC-derived hypothalamic neurons, these POMC derivatives were
appropriately trafﬁcked, secreted, and their production was signiﬁcantly (P < 0.0001) increased in response to the hormone leptin.
Conclusions: Our ﬁndings challenge the assumed pre-eminence of a-MSH and suggest that in humans, d-a-MSH and b-MSH are likely to be
the predominant physiological products acting on melanocortin receptors.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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In order to develop effective treatments for obesity, it is important to
understand the mechanisms that regulate energy homeostasis. Hy-
pothalamic neurons that produce pro-opiomelanocortin (POMC) are
important regulators of energy homeostasis in both mice [1] and
humans [2]. Severely obese patients with POMC deﬁciency dramati-
cally lose weight in response to a drug mimicking the effects of POMC-
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standing human POMC biology.
POMC protein undergoes extensive proteolytic cleavage to produce
neuropeptides that regulate food intake and energy expenditure [4,5]
(Figure 1). These peptides include desacetyl a-melanocyte stimu-
lating hormone (ACTH(1-13) amide, d-a-MSH(1-13), d-a-MSH), which
can also be acetylated to produce a-MSH(1-13). Both d-a-MSH and a-
MSH stimulate melanocortin receptor 4 (MC4R) in the brain to reduce
food intake [6e9]. POMC is also processed into b-endorphin (b-EPnit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Uni-
enerative Medicine, Wellcome Trust-Medical Research Council Cambridge Stem Cell
Neurobiology, Cavanilles Institute of Biodiversity and Evolutionary Biology, University
lty of Health Sciences, Universitat Jaume I, 12071 Castelló de la Plana, Spain 5Open
rket Road, Fordham, Cambridgeshire, CB7 5WW, UK 7Division of Diabetes, Endo-
Manchester, Manchester, UK
’s Site (B289), Keith Day Road, Cambridge, CB2 0QQ, UK. E-mail: fm436@medschl.
tandem mass spectrometry; PVH, the paraventricular nucleus of the hypothalamus;
018  Available online xxx
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 1
Figure 1: Regulation of POMC processing and secretion. Human POMC is translated as a 267-amino acid protein that, after removal of the signal peptide, undergoes successive
rounds of cleavage and trimming at dibasic residues (blue) in a tissue-speciﬁc manner; the hypothalamic pattern is illustrated. Additional levels of post-translational modiﬁcation
include C-terminal amidation (orange) and N-terminal acetylation (magenta). The most extensively characterised POMC-derived peptides that regulate food intake (green) include d-
a-MSH(1-13), a-MSH(1-13), b-MSH(1-18), b-EP (1-31) and b-EP (1-27). Illustrated mutations in b-MSH have been associated with obesity, suggesting a role for this peptide in
human body weight regulation. The concentrations of secreted POMC-derived peptides may be regulated at the levels of transcription, translation, processing, and secretion. ACTH,
adrenocorticotropic hormone; CLIP, corticotropin-like intermediary peptide; EP, endorphin; LPH, lipotropin; MSH, melanocyte stimulating hormone; NPP, POMC N-terminal region;
POMC, pro-opiomelanocortin.
Original Article(1-31)) [10,11] which stimulates the m-opioid receptor to promote
analgesia and increase food intake [12e14]. Human hypothalamic
POMC neurons might also produce b-MSH [15], which is associated
with human obesity when mutated [16e18] and inhibits feeding as
potently as a-MSH when injected into mice [18] by activating MC4R
[17e19]. However, b-MSH is not produced in the rodent brain due to
coding variants at the N-terminus of b-MSH that disrupt the dibasic
cleavage site conserved in many other vertebrates, and its existence
and biological relevance in humans remains controversial [20e22].
Since body weight is sensitive to changes in the concentration of
POMC-derived peptides [23e27], understanding POMC processing
can provide insights into molecular mechanisms of obesity that could
be therapeutically harnessed [4]. Since POMC processing is incom-
plete even in wild-type brains [10,11], stimulating POMC production or
promoting its processing might reduce body weight in obesity. For
example, the adipocyte-derived hormone leptin promotes POMC gene
expression [26,28] and POMC processing [29,30] to increase a-MSH
production in mice.
While studies in mice have been valuable, their inability to produce b-
MSH limits their utility as a model system for studying human-speciﬁc
aspects of POMC processing. Post-mortem human brain samples
provide a snapshot of peptide production, but cannot provide infor-
mation on the dynamic regulation of POMC processing and secretion.
To address these issues, we [31,32] and others [33e35] developed
methods to generate hypothalamic neurons in culture from human
pluripotent stem cells (hPSCs). Since these hypothalamic neurons can
be produced at scale and are readily manipulated, they provide an
unprecedented opportunity to study human POMC biology. POMC-
derived peptides are typically quantiﬁed using ELISAs, which provide
information about target peptides but cannot discriminate between
peptides that share common epitopes but that might have functionally-
relevant structural differences [11,36e38]. In contrast, liquid chro-
matography tandem mass spectrometry (LC-MS/MS) is sensitive and
highly speciﬁc, providing information on the precise sequence and
post-translational modiﬁcations of thousands of peptides in a single
experiment [39].2 MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier GHere, we used LC-MS/MS to analyse POMC processing in both hPSC-
derived hypothalamic neurons and primary human brain samples to
address several outstanding questions: Is b-MSH produced in the
human brain? What are the relative concentrations of POMC-derived
peptides that regulate human energy homeostasis? Are the con-
centrations of these peptides regulated by leptin in humans, as they
are in mice?
We found that hPSC-derived hypothalamic neurons trafﬁcked and
secreted POMC and its derivatives, including b-MSH(1-18), and
appropriately processed POMC into neuropeptides previously
established to regulate energy balance. We next developed quanti-
tative assays for POMC-derived peptides and found that acetylated
a-MSH was present at substantially lower concentrations than d-a-
MSH, b-MSH, or b-EP both in vitro and in vivo. Treatment with the
adipocyte-derived hormone leptin signiﬁcantly promoted the pro-
duction of these peptides in hPSC-derived hypothalamic neurons,
establishing them as a valuable tool for studying the dynamics of
POMC processing and secretion. Overall, these ﬁndings suggest that
the importance of b-MSH and d-a-MSH in human obesity has been
under-appreciated.
2. MATERIALS AND METHODS
2.1. Differentiation of hPSCs to hypothalamic and cortical neurons
Pluripotent stem cell maintenance, hypothalamic differentiation
[31,32], and cortical differentiation [40] were carried out as previously
described. Cell lines used were WA09 (H9) hESCs (Passage 38-42,
WiCell, RRID: CVCL_9773), HUES9 hESCs (Passage 32-40, Harvard
University, RRID: CVCL_0057), and FSPS13B hiPSCs (Passage 47-52,
a kind gift from L. Vallier). Experiments were carried out on hypo-
thalamic cultures 25e90 days post-differentiation, at which point
POMC could be robustly detected by immunocytochemistry. Cultures
were maintained in 24-well plates (Corning, Cat# 3524) for proteomic
experiments, in 8-well Ibidi dishes (Thistle Scientiﬁc, Cat# IB-80826)
for confocal imaging, and in Labtek 4-well chamber slides (Sigmae
Aldrich, Cat# C6932) for Immunogold EM.mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.2. Immunocytochemistry and confocal imaging
Cells were ﬁxed in 4% w/v paraformaldehyde in PBS for 10 min at
room temperature. After three washes in TBS, cultures were incubated
overnight at 4 C with primary antibody diluted in 10% normal donkey
serum in TBS with 0.1% Triton X-100. Primary antibodies used were
raised against MAP2 (1:2,000, Abcam, Cat# ab5392, RRI-
D:AB_2138153), TUJ1 (TUBB3) (1:2,000, BioLegend, Cat# 845502,
RRID:AB_2566589), or POMC (A1H5, A3H9, N1C11, used at 1:5,000,
developed by Prof. Anne White). Primary antibody was removed by
washing three times in TBS. Cells were then incubated in Alexa Fluor-
conjugated secondary antibodies (Thermo Fisher Scientiﬁc) diluted
1:500 in 10% normal donkey serum in TBS with 0.1% Triton X-100 for
2 h at room temperature. After three washes in TBS, cells were
incubated in 360 nM DAPI in TBS, and then washed an additional three
times in TBS. Cells were imaged in TBS on a Zeiss LSM 510 confocal
microscope. Images were analysed and processed with ImageJ (NIH,
RRID:SCR_003070).
2.3. Immunogold labelling
hPSC-derived hypothalamic neurons were grown in 4-well Nunc Lab-
Tek chamber slides (SigmaeAldrich, Cat# C6932) as described above.
Cells were ﬁxed in 4% paraformaldehyde and 0.5% glutaraldehyde in
0.1 M phosphate buffer (PB) for 1 h at 37 C. Pre-embedding
Immunogold labelling was performed by incubation with either
mouse anti POMC A1H5 (1:2,500; developed by Prof. Anne White) or
rabbit anti b-endorphin (1:500; Millipore, Cat# Ab5028, RRI-
D:AB_91645) primary antibodies as previously described [41].
2.4. Sandwich ELISAs for secreted POMC
ELISAs for secreted POMC were carried out as previously described
[37,38,42]. Brieﬂy, media from hPSC-derived cortical or hypothalamic
neurons (collected after 18 h of incubation with the cells) or super-
natant from samples incubated for 10 mins in KCl or ACSF (see
Stimulated secretion of POMC peptides section below for details), and
human POMC protein standards (concentration range 7.5e600 pM),
were diluted in PBS containing 4% BSA, 1% Horse Serum, 50 mg/L
Mouse IgG, 500 mg/L Bovine IgG and 0.5% Tween. The diluted
samples were then incubated overnight at 4 C in plates coated with
anti-POMC A1A12 antibody (developed by Prof. Anne White). Plates
were then rinsed with wash buffer (8.5 mM K2HPO4, 1.72 mM KH2PO4,
770 mM NaCl, 0.025% Tween-20, 0.0125% Proclin-300) and then
incubated for two hours with agitation in biotinylated N1C11 antibody
(developed by Prof. Anne White) at room temperature. After washing,
plates were incubated with avidin-HRP for 30 mins at room temper-
ature with agitation. Plates were developed using TMB (Europa Bio-
product, Cat# M0701B) for 10e30 mins at room temperature in the
dark, and then stopped by addition of 0.5 M HCl. Absorbance at
450 nm was quantiﬁed using a plate reader (Tecan M1000 Pro) and
then peptide concentration was determined by comparison with the
POMC protein standards.
2.5. Electron microscopy
Cells were post-ﬁxed in 1% osmium tetroxide and 7% sucrose in
0.1 M PB for 30 min at room temperature, washed in deionized water,
and partially dehydrated in 70% ethanol. Cells were then stained in 2%
uranyl acetate in 70% ethanol in the dark for 150 min at 4 C. Cells
were further dehydrated in ethanol, and inﬁltrated overnight in Dur-
cupan ACM epoxy resin (Fluka, SigmaeAldrich, St. Louis, USA).
Following resin hardening, embedded cell cultures were detached
from the chamber slide and glued to resin blocks. Serial semi-thin
sections (1.5 mm) were cut with an Ultracut UC-6 ultramicrotomeMOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier GmbH. This is an
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slides and lightly stained with 1% toluidine blue. Selected semi-thin
sections were glued with Super Glue-3, Loctite (Henkel, Düsseldorf,
Germany) to resin blocks and subsequently detached from the glass-
slides by repeated freezing (in liquid nitrogen) and thawing. Ultra-thin
sections (70e80 nm) were obtained with the ultramicrotome from
detached semi-thin sections, and further stained with lead citrate
(Reynolds’ solution) [43]. Finally, cells were imaged at 80 kV on a FEI
Tecnai G2 Spirit transmission electron microscope (FEI Europe, Eind-
hoven, Netherlands) equipped with a Morada CCD digital camera
(Olympus Soft Image Solutions GmbH, Münster, Germany).
2.6. Tissue homogenization and peptide extraction from cell pellets
and ACSF
To extract and solubilise peptides, cultures were partially dissociated
by treatment with 1 mM EDTA in PBS for 10 min. EDTA was then
removed, and cells were directly lysed by vigorously pipetting cells
with 80% acetonitrile (ACN, Pierce Cat# 51101) as previously
described [44,45]. This lysate was then transferred to a low protein-
binding microcentrifuge tube (Sigma, Cat# Z666505), vortexed for
1 min, and pelleted for 15 min at 12,000 g at 4 C. The supernatant
was then transferred to a new low protein-binding microcentrifuge
tube or 96-well low protein-binding plate (VWR, Cat# 951032921). In
some experiments, cells were lysed in 6M guanidine hydrochloride
(GuHCl) [46,47] (Sigma, Cat# G4505) to aid in peptide extraction [48]
and transferred to low-protein-binding microcentrifuge tubes (Sigma,
Cat# Z666505). Lysates were snap-frozen on dry ice and thawed on
ice three times, before four parts 80% acetonitrile were added and
mixed thoroughly. Phases were separated by centrifugation for 5 min
at 12,000 g at 4 C. The aqueous (lower) phase was transferred to a
fresh low protein-binding microcentrifuge tube or 96-well plate as
described above.
For extraction of peptides from C57BL/6 mouse plasma, 50 mL of
plasma was precipitated with 300 mL of 80% ACN in water (v/v) and
then centrifuged at 12,000  g. The supernatant was then transferred
to fresh low-protein-binding Eppendorf tubes as described above. Both
mouse and human samples were either immediately processed, or
stored at 80 C and thawed on ice before being dehydrated in an
evaporating centrifuge or with pure nitrogen at 40 C on an SPE Dry
evaporator system (Biotage, Uppsala, Sweden). Dehydrated peptides
were reconstituted with 0.1% formic acid in dH2O, spiked with stable
isotope-labelled internal standards for d-a-MSH(1-13), b-MSH(1-18)
and b-EP (1-31), and loaded onto a HLB Prime micro elution plate
(Waters, Cat# 186008052) for solid-phase extraction. Plates were
washed with 200 mL 0.1% formic acid in dH2O (v/v), followed by a
wash with 200 mL 1% acetic acid with 5% methanol in dH2O (v/v/v).
Samples were eluted with 2  30 mL of 60% Methanol in dH2O with
10% Acetic acid (v/v) and diluted further with 75 mL of 0.1% formic
acid in dH2O (v/v) and stored at 80 C until loading onto LC columns
for MS/MS.
ACSF from stimulation experiments was collected and immediately
snap-frozen on dry ice and stored at 80 C. Samples were then
thawed on ice, followed by spike-in of 500 pg stable-isotope internal
standards for a-MSH(1-13), d-a-MSH(1-13), b-MSH(1-18) and direct
solid-phase extraction, as described above.
2.7. Stimulated secretion of POMC-derived peptides
hPSC-derived neurons were washed three times with HEPES-buffered
ACSF consisting of 129 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, 25 mM HEPES, 11.1 mM Glucose. For experiments in which
POMC was detected by ELISA, cells were incubated in ACSF for 10 minopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 3
Original Articleat 37 C. The supernatant was collected and snap-frozen on dry ice.
After removing the ACSF, cells were incubated for 10 min at 37 C in
either ACSF or a 129 mM KCl solution consisting of 5 mM NaCl,
129 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 25 mM HEPES, and 11.1 mM
glucose [49,50] to potently depolarise cells. For experiments in which
POMC-derived peptides were detected by LC-MS/MS, we used longer
incubation times (90 mins) combined with lower KCl concentrations
(30 mM) in order to more gently depolarise cells. Here, cells were
incubated in ACSF for 90 min at 37 C to reduce tonic release, after
which the supernatant was collected and snap-frozen on dry ice, and
cells were incubated for 90 min at 37 C in either ACSF or a 30 mM KCl
solution consisting of 104 mM NaCl, 30 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, 25 mM HEPES, and 11.1 mM glucose to depolarise cells.
Media supernatants from control ACSF or KCl treatments were stored
at80 C. To account for slight well-to-well variation in the amount ofFigure 2: Subcellular localisation of POMC and its derivatives in hPSC-derived hypothalam
into hypothalamic POMC neurons that mature over time in culture. Experiments were ca
entiation yields predominantly neuronal cultures as indicated by immunostaining for Tuj
micrographs of punctate POMC-immunoreactive structures localised to cell bodies and neu
for POMC (red staining). E-G) Transmission electron micrographs showing speciﬁc cytoplasm
rounded, vesicle-like structures (G, yellow arrows) in regions with abundant vesicles res
vesicles (F, black arrows). H) Quantiﬁcation of the diameters of neurotransmitter-like (NT
and dense core-like (DC-like, blue circles) vesicles in hPSC-derived hypothalamic neuron
positive structures (p < 0.0001). Error bars show SEM. ****, P < .0001.
4 MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier GPOMC neurons or POMC-derived peptide production, KCl-induced
secretion during the stimulation period (Figure 6) was normalized by
subtracting the quantiﬁed pre-stimulation value for each POMC-
derived peptide from the post-stimulation value.
2.8. Regulation of MSH concentration by exogenous factors
hPSC-derived hypothalamic neuronal cultures were dissociated after
D25, at which point POMC neurons could clearly be visualised by
immunoctyochemistry, and re-plated in parallel cultures as previously
described [32]. After 24 h of recovery, media was changed and cul-
tures were treated for either 24 h (n ¼ 1 cell line, 2 experiments) or 9
days (n ¼ 2 cell lines, 1 experiment) with experimental agents. These
included leptin (PeproTech, Cat# 300-27) reconstituted in PBSþ 0.1%
BSA to a ﬁnal concentration of 10 ng/mL, 100 ng/mL, 1 mg/mL or
vehicle (PBS þ 0.1% BSA), and Furin Inhibitor 1 (Cayman Chemicalic neurons. A) Schematic diagram of the differentiation of human pluripotent stem cells
rried out between 25 and 90 days post-differentiation. B) Human hypothalamic differ-
1 and MAP2, of which approximately 6% are immunopositive for POMC. C) Confocal
rites (inset). D) Some Tuj1-expressing axon-like processes are strongly immunopositive
ic and punctate labelling by Immunogold staining for b-EP (F) or a-MSH (G) localised to
embling dense core vesicles (G, black arrows), and adjacent to neurotransmitter-like
-like, black circles) clear vesicles, POMC Immunogold-positive (POMC-IG, red circles),
s. Neurotransmitter-like vesicles were signiﬁcantly smaller than POMC Immunogold-
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 3: Identiﬁcation of processed POMC peptides by LC-MS/MS. A) Schematic workﬂow for the quantiﬁcation of POMC-derived peptides from hPSC-derived hypothalamic
neurons. B) Liquid chromatographs of samples from hPSC-derived hypothalamic neurons (top), compared with stable isotope-labelled synthetic d-a-MSH(1-13), b-MSH(1-18) and
b-EP (1-31) (bottom). Note that heavy isotope-labelled reference peptides have identical retention times as endogenous peptides but have slightly higher mass-to-charge (m/z)
ratios, and that m/z values measured from Orbitrap and triple quadrupole mass spectrometers may differ. C) Schematic of human POMC protein and relevant dibasic cleavage sites
(blue), expected POMC-derived peptides, and those peptides detected in hPSC-derived hypothalamic cultures by LC-MS/MS. Detected peptides included g1-MSH (Lys- g1-MSH),
d-a-MSH(1-13), b-MSH(1-18) and b-EP (1-31). Quantiﬁed peptides are indicated in green. D) Summary of POMC-derived peptides detected by LC-MS/MS, where the colour
intensity represents the relative abundance of each peptide species. Repl., replicates. Other abbreviations are as in Figure 1.Co., Cat# B00165) reconstituted in DMSO and added to a ﬁnal con-
centration of 25 mM or vehicle (DMSO to 0.1% ﬁnal concentration).
Cultures were then processed for LC-MS/MS as described above.
2.9. Peptide discovery by LC-MS/MS
Peptide extracts were run using nano-ﬂow-based separation and
electrospray approaches on a Thermo Fisher Ultimate 3000 nano-LCMOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comsystem coupled to a Q Exactive Plus Orbitrap mass spectrometer
(ThermoScientiﬁc, San Jose, USA) as described previously [44]. Ex-
tracts were injected at a ﬂow rate of 30 mL/minute onto a peptide trap
column (0.3  5 mm; ThermoFisher Scientiﬁc), washed for 15 min,
and switched in line with a nano-easy column (0.075  250 mm;
ThermoFisher Scientiﬁc) ﬂowing at 300 nL/minute. Both nano and trap
column temperatures were set at 45 C during the analysis. Theopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 5
Figure 4: Quantiﬁcation of POMC-derived peptides in hPSC-derived neurons and primary human hypothalamus. A) Schematic diagram of standard curve generation for peptide
quantiﬁcation. B) LC-MS/MS-based quantiﬁcation of d-a-MSH, a-MSH, b-MSH and b-EP peptides in hPSC-derived POMC neurons. N ¼ 5 independent experiments with 3e8
replicates per experiment. Concentrations were converted to molarity and then normalised to the mean concentration of d-a-MSH for each technical replicate. Error bars show
SEM. C) Quantiﬁcation of POMC-derived peptides in primary human brain samples. Note that while a-MSH was clearly detected in PVH Brain 1 Right and Left and MBH Brain 1
Right, the concentration was below the assay’s limit of accurate quantiﬁcation. N ¼ 3 independent samples from N ¼ 2 brains per brain region. PVH, dissected region
encompassing the paraventricular hypothalamus; MBH, dissected region encompassing the mediobasal hypothalamus. Error bars show SEM.
Original Articlebuffers used for nano-LC separations were A: 0.1% formic acid in
water (v/v) and B: 0.1% formic acid (v/v) in 80:20 ACN/water. Initial
starting conditions were 2.5% B (equating to 2% ACN), and held for
5 min. A ramp to 50% B was performed over 135 min, followed by a
wash with 90% B for 20 min before returning to starting conditions for
20 min, totalling an entire run time of 190 min. Electrospray analysis
was performed using a spray voltage of 1.8 kV, the tune settings for
the MS used an S-lens setting of 70 v to target peptides of higher m/z
values. A full scan range of 400e1600 m/z was used at a resolution of
75,000 before the top 10 ions of each spectrum were selected for MS/
MS analysis. Existing ions selected for fragmentation were added to an
exclusion list for 30 s.
2.10. Peptide identiﬁcation using peaks
The acquired LC-MS/MS ﬁles were searched using Peaks 8.5
software (Waterloo, ON, Canada) against the Homo sapiens Swis-
sprot database for human samples, or the Mus musculus Swissprot
database for mouse plasma samples (06-May-2016, 26-October-
2017). A no-digest setting was used, which enabled peptides of up
to 65 amino acids in length to be matched, and precursor and
product ion tolerances were set at 10 ppm and 0.05 Da, respec-
tively. A ﬁxed post-translational modiﬁcation of carbamido-
methylation was applied to cysteine residues, whilst variable
modiﬁcations included methionine oxidation, N-terminal pyro-
glutamate, N-terminal acetylation and C-terminal amidation. A
minimum of 1 unique peptide and a false discovery rate value of 1%
was used to ﬁlter the results.6 MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier G2.11. Peptide quantiﬁcation by LC-MS/MS
Calibration standards of synthetically-produced a-MSH(1-13), d-a-
MSH(1-13), b-MSH(1-18) and b-EP (1-31) (Bachem, Bebendorf,
Switzerland) were diluted to 10-10,000 pg/mL or 100-100,000 pg/mL
in a matrix of 0.001% BSA in 0.1% formic acid (v/v), or in lysates from
cultured cortical neurons that contained no detectable POMC peptides
to mimic the protein and lipid composition from hypothalamic neuron
extracts. Calibration standards were then spiked with 500 pg custom-
ordered stable-isotope internal standards (Cambridge Research
Biochemical Ltd.) for:
d-a-MSH(1-13): SYSMEH-[U-13C9,
15N-Phe]-RWGKPV-amide
b-MSH(1-18): DEGPYRMEH-[U-13C9,15N-Phe]-RWGSPPKD-acid
b-EP (1-31): YGGFMTSEKSQTP-[U-13C6,
15N-Leu]-VT-[U-13C5,
15N-
Leu]-[U-1 3C9,
15N-Phe]-FKNAIIKNAYKKGE-acid
Samples were extracted using the solid phase extraction method
described above. LC-MS/MS instrumentation used for the quantitation
of the POMC-derived peptides included a H-Class Acquity (Waters)
attached to a TQ-XS triple quadrupole mass spectrometer (Waters).
Sample (10 mL) was injected onto a 2.1 50 mm 1.8 mm particle HSS
T3 Aquity column held at 60 C and ﬂowing at 700 mL/minute.
Gradient starting condition were 87.5% A (0.1% formic acid in water v/
v) and 12.5% B (0.1% formic acid in ACN). Starting conditions were
held for 30 s before raising to 30% B over 2.5 min. The column was
ﬂushed with 90% B for 1.1 min before returning to starting conditions.
The total time of each analysis was 5 min, with the ﬁrst 1.1 min andmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 5: Characterisation of the peptidome of the human hypothalamus. A) Sagittal view of the right hemisphere of a post-mortem human forebrain used in this study. Regions of
approximately 3  3  3 mm from the indicated brain regions were dissected for analysis. B) Colour-coded schematic diagram of several neuropeptidergic cell types of interest. C)
Summary of peptides associated with the regulated secretory pathway, synaptic proteins, and neuropeptide processing enzymes detected in hPSC-derived hypothalamic neurons
in vitro or in the MBH, PVH, or CTX of the human brain. Filled boxes represent peptides corresponding to the indicated gene that were detected and automatically identiﬁed. D)
Summary of select neuropeptides detected in hPSC-derived hypothalamic neurons or in the human brain. Sequences too long to readily display are denoted by an ellipsis. CTX,
cortex (orbitofrontal gyrus); LHA, lateral hypothalamic area; MBH, mediobasal hypothalamus; Pit., pituitary gland; PVH, paraventricular nucleus of the hypothalamus, Unchar. Pep.,
uncharacterised peptide. An adjoining ‘p’ on the amino acid sequences denotes a pyroglutamate residue, while an ‘a’ denotes an amide group. N ¼ 4 independent samples from
N ¼ 3 unrelated fresh post-mortem brains.
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Original Articlelast 1.8 min diverted to waste. Mass spectrometry conditions involved
targeting four POMC-derived peptides, and the transition and collision
energy details for each peptide, along with associated internal stan-
dards are given in Table 1.
The source parameters used included a positive electrospray ion spray
voltage of 3.0 kV, gas ﬂow of 1000 L/hour, desolvation temperature of
600 C and a cone voltage of 40 V. Peptide peak areas were integrated
using the TargetLynx program associated with Masslynx V 4.2 (Wa-
ters), and peptide peak areas were ratiometrically compared against
their corresponding stable isotope-labelled internal standard peptide.
The POMC-derived peptide peak area ratio concentrations in extracted
samples were compared against the calibration lines to assign con-
centration values. The peptide calibration lines showed consistent
results over a thousand-fold range of peptide concentrations
(R2 > 0.98 for all peptides).
2.12. Human brain samples
Fresh human brain samples were obtained from three donors of un-
known body mass index who had previously given informed consent
via the Cambridge Brain Bank after ethical committee approval.
Samples were from a 75-year-old woman, 81-year-old woman with no
medical history or obvious pathological evidence of neurodegeneration,
and from a 79-year-old man with signs of multiple system atrophy.
After death, brains were dissected from the skull and stored in
phosphate buffered saline (PBS) at 4 C for 24 h, 57 h, and 48 h
respectively, until the time of dissection. After dissection, samples
were immediately snap frozen in 6 M guanidine hydrochloride, stored
at80 C, and then processed and analysed by LC-MS/MS. Dissected
brain regions of approximately 3  3  3 mm encompassed the
mediobasal hypothalamus (MBH) that should contain POMC cell
bodies, the paraventricular nucleus of the hypothalamus (PVH) that
should contain POMC neuron axon terminals, and a small piece of the
orbitofrontal gyrus of the cerebral cortex (CTX) extending through all
cortical layers. Immediately after dissection, primary samples wereTable 2 e Summary of post-mortem human brain samples ﬁles names and sam
Sample ID Sample Type Data ﬁle name Age
Brain 1 Left, Right MBH, PVN, CTX n/a 79
Brain 2 Right MBH, PVN, CTX n/a 81
Brain 3 Left MBH ARC brain 1 75
Brain 3 Right MBH ARC brain 2 75
Brain 3 Left PVN PVN brain 1 75
Brain 3 Right PVN PVN brain 2 75
Brain 3 Cortex Cortex, orbitofrontal gyrus CTX Brain 1 75
hPSC-derived cortical
neurons
Cultured cortical neurons
(WA09 ES line)
Cortex neurons ACN n/a
hPSC-derived hypothalamic
neurons
Cultured hypothalamic neurons
(HUES9 ES line)
POMC neuron GuHCL n/a
Table 1e Peptide transitions (Q1, Q3), collision energies and dwell time for
POMC peptide standards and internal standards. m, mass; z, charge; eV,
electron volts; ms, milliseconds; IS, internal standard.
Peptide Q1
(m/z)
Q3
(m/z)
Collision energy
(eV)
Dwell time
(ms)
d-a-MSH 406.55 458.13 12 40
d-a-MSH IS 409.05 461.56 12 40
a-MSH 555.98 686.75 19 40
b-MSH 552.1 654.08 20 40
b-MSH IS 554.6 567.41 20 40
b-Endorphin (1-31) 693.62 825.89 22 40
b-Endorphin (1-31) IS 698.52 832.19 22 40
8 MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier Gdisrupted in 6M GuHCl at 4 C in Lysing Matrix D tubes (MPbio, Cat#
116913100) to stabilise and extract peptides, and then fully homog-
enized using a Fastprep 24 5G homogeniser (MPbio) using four 40 s
runs at 6 m/s separated by 5 min of cooling on ice between each
homogenisation cycle. Samples were stored at 80 C or processed
and analysed immediately as described above.
2.13. Statistical analysis
Statistical analyses in Figures 2H, 6C, 7B,C, S1E were carried out using
Prism (GraphPad, RRID:SCR_002798). Signiﬁcance was calculated using
the Holm-Sidak method, with alpha 0.05. Error bars in Figures 2H, 4B,C,
6C, 7B,C, S1C,E, S3B show the standard error of the mean (SEM).
2.14. LC-MS/MS data
The mass spectrometry peptidomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with
the dataset identiﬁer PXD008795 and 10.6019/PXD008795 (http://
proteomecentral.proteomexchange.org). Explanation of ﬁle names is
summarised in Table 2.
3. RESULTS
3.1. Human hypothalamic neurons appropriately trafﬁc and secrete
POMC in vitro
To determine if in vitro-derived human POMC neurons could be a
suitable model system for studying POMC processing, we differenti-
ated human embryonic stem cells (hESCs) and human induced
pluripotent stem cells (hiPSCs) into hypothalamic neurons as previ-
ously described [31,32] (Figure 2A). After 28 days of differentiation,
cultures expressed hypothalamic marker genes such as NKX2.1, and
predominantly contained cells with neuronal morphology that
expressed the neuronally-enriched proteins tubulin beta 3 class III
(TUBB3, Tuj1) and microtubule associated protein 2 (MAP2)
(Figure 2B). We observed that 6.5  0.76 percent of neurons were
strongly immunoreactive for POMC, as visualised by several distinct
antibodies (Figure 2BeD).
Since POMC is packaged into dense core vesicles as it is progres-
sively processed [51e54], we examined the subcellular localization
of POMC-immunoreactive epitopes by high-magniﬁcation immuno-
ﬂuorescent confocal microscopy and found that they localised to
punctate structures within the cell body and in MAP2 and Tuj1-
expressing neurites (Figure 2C,D). To ask if these structures corre-
sponded to dense-core vesicles, we performed Immunogold labelling
with antibodies recognising epitopes corresponding to sequences in
a-MSH or bEP and their precursor peptides, and examined sam-
ples by transmission electron microscopy. Immunogold particles
(Figure 2EeG) localised to rounded structures 103.5  4.5 nm inples types for the peptidomics data deposited on the PRIDE partner repository.
Sex Cause of Death Post-Mortem Interval LC-MS Analysis type
Male Multiple system atrophy 48 h Quantitative and Nano-ﬂow
Female Leukaemia 60 h Quantitative and Nano-ﬂow
Female Kidney Cancer 24 h Nano-ﬂow
Female Kidney Cancer 24 h Nano-ﬂow
Female Kidney Cancer 24 h Nano-ﬂow
Female Kidney Cancer 24 h Nano-ﬂow
Female Kidney Cancer 24 h Nano-ﬂow
n/a n/a n/a n/a
n/a n/a n/a n/a
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
diameter that were similar in appearance and localisation (Figure 2G,
yellow arrows) to electron-opaque dense-core vesicles (Figure 2G,
black arrows) that averaged 136.4  9.84 nm in diameter
(Figure 2H). In contrast, numerous clear neurotransmitter-like vesi-
cles (Figure 2F, arrows) were signiﬁcantly (P < 0.0001) smaller in
diameter at 36.6 1.6 nm (Figure 2H). Overall, these measurements
are similar to those reported in vivo for neurotransmitter-containing
vesicles (30e50 nm) and dense-core vesicles (100e250 nm) in
both rodents [55e58] and humans [59,60]). These results suggest
that POMC and/or its derivative peptides are likely packaged into
vesicles that mature into dense-core vesicles.
Since these ﬁndings suggested that POMC might be secreted, we
analysed the culture media collected from hPSC-derived cortical or
hypothalamic cells using a sensitive (detection limit w7.5 pM)
sandwich ELISA. This assay detects epitopes in ACTH(10-18) and NPP
[37,38,42], both of which are present in full-length POMC and in pro-
ACTH (Figures 1, S1A,B). We could readily detect these species in
media from hypothalamic cultures but not from cortical cultures
(Fig. S1C), consistent with their constitutive secretion and/or secretion
in response to spontaneous neuronal activity present during standard
culture conditions. To test if secretion might be stimulated by depo-
larisation, we treated cultures with potassium chloride (KCl) (Fig.S1D)
and observed a signiﬁcant (P < 0.01) 6.3  0.16-fold increase in
secreted POMC and/or pro-ACTH (Fig. S1E).
3.2. hPSC-derived hypothalamic neurons produce b-MSH(1-18)
and other POMC-derived peptides
To identify which POMC-derived peptides were produced in human
hypothalamic neurons, we extracted peptides using either 80%
acetonitrile (ACN) or 6M guanidine hydrochloride (GuHCl) and ACN,
followed by solid-phase extraction and analysis by nanoﬂow LC-MS/
MS [61] (Figure 3A). We observed similar types of peptides using
these two extraction methods, but found that GuHCl treatment
increased both the number of unique peptides and the depth of spectra
observed per peptide (Table S1).
To test whether hPSC-derived hypothalamic neurons processed POMC
into peptides important for energy homeostasis, we obtained custom-
synthesised d-a-MSH(1-13), b-MSH(1-18) and b-EP (1-31) with
speciﬁc amino acids substituted for 13C and 15N stable isotopically
labelled equivalents, and spiked these internal standards into cell ly-
sates during peptide extraction (Figure 3A). A single d-a-MSH standard
was used for quantiﬁcation of both d-a-MSH and a-MSH to ensure
accurate relative quantiﬁcation, since these peptides have very similar
chemical properties. Stable isotope-labelled standards have shifted
mass-to-charge ratios (m/z) compared with endogenous peptides, but
are otherwise chemically identical, resulting in identical column
retention times during liquid chromatography (Figure 3B).
We then identiﬁed peptides present in samples from two unrelated
hESC lines and one hiPSC line using an automated peptide identiﬁ-
cation pipeline (see Materials and Methods). We consistently observed
POMC-derived peptides in hPSC-derived hypothalamic cultures,
constituting 3.35  1.87% of all peptide alignments (Table S2), but
never observed them in hPSC-derived cortical-like cells. The vast-
majority of unique spectra for POMC-derived peptides of interest
(50/69, 72.4%) were ﬂanked by dibasic residues that are targeted by
POMC-processing enzymes (Figure 3C), and some peptides were C-
terminally amidated as is seen in vivo (e.g. d-a-MSH), indicating that
the observed peptides were unlikely to be random degradation prod-
ucts (Figure 3D). We identiﬁed the POMC-derived neuropeptides d-a-
MSH, b-MSH and b-EP (1-31) as well as b-EP (1-27), g1-MSH (Lys-
g1-MSH) [62], CLIP, N-LPH, and joining peptide (Figures 1 and 3C).MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier GmbH. This is an
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duction [63] by providing the speciﬁc sequences and post-translational
modiﬁcation patterns of these peptides and establishing that b-MSH(1-
18) is produced by human hypothalamic neurons.
We were surprised to readily detect spectra for b-MSH(1-18), the
existence of which has been disputed [21], whereas we did not
consistently detect spectra for a-MSH(1-13), which has been the
subject of intense study [7,8,30,64,65] and is thought to be more
stable than d-a-MSH [30]. Upon manual review of the raw data, we
could indeed ﬁnd peaks with m/z and column retention times appro-
priate for a-MSH. We therefore wondered what the relative concen-
trations of POMC-derived peptides relevant for human energy
homeostasis might be in vitro and in vivo.
3.3. d-a-MSH(1-13), b-MSH(1-18), and b-EP(1-31) are produced
in excess of a-MSH(1-13)
To address this question, we developed quantitative assays [44] for a-
MSH(1-13), d-a-MSH(1-13), b-MSH(1-18) and b-EP (1-31)
(Figure 4A) by generating calibration lines of these synthetic peptides
that enabled accurate (R2 > 0.98) peptide quantiﬁcation over a broad
range and down to at least 10 pg/ml (2.9e6 pM) (Fig. S2). We then
compared extracted samples from hPSC-derived hypothalamic neu-
rons to the calibration line, using the stable isotopically labelled internal
standards as a normalising factor for each peptide.
In hPSC-derived hypothalamic cultures, we found that target peptides
were typically present at concentrations greater than 540 pM, well
above the quantiﬁcation limit of the assay. Upon comparing the relative
concentrations of these peptides across four independent experiments,
we found that the concentrations of d-a-MSH and b-MSH were
approximately equimolar (1.00  0.03: 0.88  0.05) (Figure 4B). In
contrast, we observed a-MSH concentrations to be approximately one
hundredth the concentration of d-a-MSH (0.009  0.001) and often
near the assay’s lower limit for accurate quantiﬁcation, whereas b-EP
(1-31) concentrations were 3.82  0.18- fold higher than that of d-a-
MSH (Figure 4B).
The analysis of hPSC-derived hypothalamic cultures yielded many
results consistent with what has been described in other experimental
systems, but we were surprised by the dramatically higher abundance
of both d-a-MSH and b-MSH relative to a-MSH, and the even higher
concentrations of b-EP. To test whether observations made in vitro
were predictive of the concentrations of these peptides in vivo, we
therefore obtained three fresh post-mortem human brain samples and
dissected regions encompassing the mediobasal hypothalamus (MBH),
the paraventricular nucleus of the hypothalamus (PVH), and a small
piece of the orbitofrontal gyrus of the cerebral cortex (CTX) from each
brain (Figure 5A,B). By nanoﬂow LC-MS/MS analysis of these brain
samples, we identiﬁed an average of 2089  854 peptides from
4472  2355 spectra per sample, corresponding to 382  86 unique
proteins, comparable to what we observed in hPSC-derived hypotha-
lamic neuronal cultures (2164  691 peptides, 4827 1642 spectra,
588 170 unique proteins per sample) (Table S2). In each sample, we
observed peptide fragments of proteins associated with synaptic
function and regulated secretion, indicating efﬁcient peptide extraction.
In primary human hypothalamic samples, we detected fragments of
several key enzymes involved in neuropeptide processing, including
PCSK1 (PC1/3), PCSK2 (PC2) and CPE (Figure 5C). Primary human
MBH and PVH samples contained the POMC-derived peptides a-
MSH(1-13), d-a-MSH(1-13), b-MSH(1-18) and b-EP (1-31), along
with a broad array of other neuropeptides such as agouti-related
peptide (AGRP) (Figure 5D). Many of the peptides identiﬁed in the
human brain were also present with identical structures and post-open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 9
Original Articletranslational modiﬁcations in hPSC-derived hypothalamic neurons
(Figure 5D).
Next, we added stable-isotope-labelled internal standards, applied the
quantitative LC-MS/MS quantiﬁcation methods described above, and
found that b-MSH was indeed present in the adult human MBH and
PVH at concentrations comparable to that of d-a-MSH (Figure 4C). We
also found that b-EP (1-31) was present at approximately 2- to 3-fold
higher concentrations than d-a-MSH or b-MSH, while concentrations
of acetylated a-MSH concentrations were at least 6-fold lower than
those of either d-a-MSH or b-MSH, and were often below the limit for
accurate quantiﬁcation (Figure 4C).
To test whether human a-MSH might be preferentially lost during solid
phase extraction, we spiked POMC peptide standards into cellular
extracts from hPSC-derived cortical neurons (Fig. S3A) and found that
concentrations of POMC-derived peptides were similar before and after
solid-phase extraction (median ratio 1:0.99), indicating minimal
sample loss or peptide-speciﬁc extraction biases (Fig. S3B). In addi-
tion, we found that acetylated POMC-derived peptides, including a-
MSH, were readily detectable from mouse plasma using the same
peptide extraction and LC-MS/MS methods used to analyse human
neuronal samples, ruling out any potential detection bias (Fig. S4) [66].
To test whether the higher concentration of b-EP (1-31) relative to d-a-
MSH(1-13) and b-MSH(1-18) could be explained by technical arte-
facts, such as degradation of the standard peptide, we acquired a fresh
stock of synthetic b-EP (1-31) and found good agreement (within 16%)
with our previous measurements, indicating that the substantially
higher concentrations of b-EP (1-31) we observed were not likely due
to degradation of the stock peptide.
Overall, the broad agreement between ﬁndings from our in vitro culture
system and primary human brain tissue demonstrate that hPSC-
derived hypothalamic neurons have predictive value and suggest
that they might also provide insights into the regulation of POMC
expression, processing, and secretion.
3.4. Human hypothalamic neurons secrete POMC-derived peptides
upon depolarisation
To test whether hPSC-derived hypothalamic cultures secrete POMC-
derived melanocortins, we replaced the culture media with artiﬁcial
cerebrospinal ﬂuid (ACSF) and analysed the ACSF by quantitative LC-
MS/MS after a brief incubation period. We readily observed d-a-MSH,
b-MSH and b-EP (but not acetylated a-MSH) at concentrations within
the linear range for LC-MS/MS-based quantiﬁcation indicating that
POMC-derived peptides are robustly secreted (Figures 6A,B, S2).
Since POMC-derived peptides were localised to dense core vesicle-
like structures in hPSC-derived hypothalamic neurons (Figure 2FeH),
we hypothesised that their secretion might be enhanced by depo-
larisation. Following ACSF pre-stimulation, we therefore switched
cultures to either ACSF (control) or to ACSF containing 30 mM KCl to
induce depolarisation (Figure 6A) and found that KCl treatment led to
signiﬁcantly (P < 0.0001) higher concentrations (3.5- to 8.5-fold) of
POMC-derived peptides (Figure 6C), suggesting robust stimulated
secretion. The molar ratios of secreted d-a-MSH: b-MSH: b-EP in
both ACSF and KCl-treated samples were approximately 0.4: 1.0: 3.7
(Figure 6B), broadly resembling the ratios observed in cell lysates
(approximately 1.1: 1.0: 4.3) (Figure 4B) with the exception of d-a-
MSH, which appeared to be less abundant in the supernatant than in
cell lysates. Together, these results suggest that POMC-derived
peptides were appropriately trafﬁcked into regulated secretory ves-
icles (Figure 2CeH) and secreted upon depolarisation.10 MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier G3.5. Leptin increases MSH and b-EP concentrations in human
hypothalamic neurons
The regulation of POMC production or processing can alter the pool of
neuropeptides available for secretion, which could in turn modulate the
downstream effects of POMC-derived peptides on energy homeosta-
sis. Since leptin stimulates POMC neurons [67] and induces POMC
gene expression in mice [28], we hypothesized that treatment with
leptin might alter the concentration of POMC-derived peptides in hu-
man hypothalamic neurons.
As the concentrations of a-MSH were close to the limit of accurate
quantiﬁcation, we selected the more abundant peptides d-a-MSH, b-
MSH and b-EP to test this hypothesis. First, to investigate whether
changes in neuropeptide processing were detectable by our methods,
we added either vehicle or a broad-spectrum inhibitor of prohormone
convertases (25 mM Furin Inhibitor 1) to hPSC-derived hypothalamic
neurons (Figure 7A). We then extracted peptides from cell lysates,
added internal standards, performed quantitative LC-MS/MS, and
observed a 23e45% decrease in the measured concentration of d-a-
MSH (P< 0.0001), b-MSH (P< 0.0001) and b-EP (P< 0.05) in drug-
treated cultures relative to vehicle controls (Figure 7B). Next, we
treated cultures with either vehicle or 10 ng/mL (625 pM), 100 ng/mL
(6.25 nM) or 1 mg/mL (62.5 nM) human leptin and observed a sig-
niﬁcant (P < 0.05 to P < 0.0001) 18e52% increase in the concen-
tration of all tested POMC-derived peptides at all tested leptin
concentrations (Figure 7C). These results indicate that dynamic
changes in POMC peptide concentration are detectable in vitro by
quantitative proteomic methods, and that cultured human hypotha-
lamic neurons functionally respond to physiologically-relevant con-
centrations of leptin by altering POMC production and/or processing.
4. DISCUSSION
In this study, we used LC-MS/MS to identify and quantify peptides in
hPSC-derived neurons and in the human brain. To quantify POMC-
derived peptides of interest, we developed quantitative LC-MS/MS-
based methods with the aid of stable isotope-labelled internal stan-
dards. These methods had comparable sensitivity to most ELISAs and
greater speciﬁcity, since antibodies may recognise multiple similar
forms of a peptide [68e70]. Our analysis revealed several noteworthy
ﬁndings.
First, we found that key POMC-derived peptides were appropriately
processed in vitro in all hPSC lines analysed and had identical struc-
tures to those identiﬁed in vivo, including post-translational modiﬁ-
cations. Although we typically observed over 2000 unique peptides per
sample, these results are not exhaustive, since degradation in the
post-mortem interval may have affected the peptide concentrations
measured in primary human brain samples, larger peptides may be
precipitated by ACN [71], and glycosylated peptides are not readily
detected by the automated analysis pipeline we employed (see Ma-
terials and Methods).
We demonstrate using quantitative techniques with structural-level
resolution that b-MSH is present at substantial concentrations in
both hPSC-derived neurons and in the human hypothalamus. These
data are consistent with previous reports that used distinct method-
ologies. In particular, immunohistochemistry for b-MSH is suggestive
but likely fails to discriminate between epitopes unique to b-MSH and
those present in its precursors and therefore is open to multiple in-
terpretations [18]. Similarly, HPLC has been used to demonstrate the
presence of peptides with chemical properties consistent with b-MSHmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 6: Regulated secretion of POMC-derived peptides. A) Experimental schematic for quantifying the stimulated secretion of POMC-derived peptides in hPSC-derived hy-
pothalamic neurons by LC-MS/MS. B) Secreted d-a-MSH, b-MSH and b-EP (1-31) peptides in pre-stimulation controls (black circles), 30 mM KCl stimulations (red circles) and
ACSF controls (blue circles). Molar peptide concentrations were normalised to the mean pre-stimulation b-MSH concentration. N ¼ 4 independent experiments with 4e8 technical
replicates per experiment. C) KCl-induced changes in secreted peptide concentration were calculated from data shown in (B) for each technical replicate by subtracting the pre-
stimulation peptide concentrations from the ACSF control or KCl stimulation condition, and normalising to mean concentrations seen in ACSF control-stimulated cultures. KCl
stimulation signiﬁcantly (P < 3  105) increased the concentrations of d-a-MSH, b-MSH and b-EP (1-31). KCl, potassium chloride. Error bars show SEM. ****, P < .0001.[15], but this technique does not provide sequence information and it
has been suggested that the observed 18- and 22-amino-acid species
of b-MSH might be artefacts generated during peptide isolation [20e
22,72]. In our LC-MS/MS studies, we were able to directly observe
peptide sequences, including degradation products, and found that the
predominant species of b-MSH was the 18-amino-acid form predicted
by the location of dibasic cleavage sites. Furthermore, we found that it
was present at a roughly equimolar ratio to d-a-MSH, consistent with it
being a true neuropeptide.
Several lines of evidence suggest that the importance of b-MSH in
regulating energy homeostasis in the human brain has not been fully
appreciated. First, it is sufﬁcient to reduce food intake in rodents [7,73]
with similar potency to a-MSH [18]. Second, human mutations
affecting either a dibasic cleavage site [16] or a conserved tyrosine
residue of b-MSH important for MC4R binding [17,18] are strongly
associated with obesity, suggesting that b-MSH is of direct clinical
relevance and that its loss cannot be compensated by either a-MSH
and/or d-a-MSH. Finally, dogs carrying frameshift mutations in POMC
that affect b-MSH but not a-MSH lead to increased appetite and body
weight [19]. Since b-MSH is not produced in rodents, hPSC-derived
hypothalamic neurons provide a novel opportunity for studying the
generation and regulation of this important peptide.MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier GmbH. This is an
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thalamus, we found that acetylated a-MSH was present at substan-
tially lower concentrations than d-a-MSH, b-MSH, or b-EP (1-31). In
agreement with these results, d-a-MSH was previously shown to be
more abundant than a-MSH in the rodent hypothalamus [30,74e77]
and human brain [78]. It is unlikely that the acetyl group was lost
from a-MSH during sample preparation, since we did not observe
signiﬁcant peptide fragmentation indicative of degradation and acet-
ylation is a stable peptide modiﬁcation. In addition, the acetylated a-
MSH peptide standard was efﬁciently recovered during solid phase
extraction (Fig. S3), and acetylated a-MSH is robustly detected from
mouse plasma using very similar sample preparation methods [66]
(Fig. S4). It has been suggested that d-a-MSH may be acetylated
immediately before secretion [9] and that leptin increases N-terminal
acetylation of d-a-MSH [30], but concentrations of secreted a-MSH
were too low in our culture system to enable these hypotheses to be
directly tested. Further development of peptide quantiﬁcation methods
may allow these questions to be addressed in future studies.
Since both a-MSH and d-a-MSH are likely secreted, what might the
roles of each of these peptides might be in human energy homeo-
stasis? Previous studies using acute peptide injections suggested that
d-a-MSH is less potent at reducing food intake in rodents than a-MSHopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 11
Figure 7: Regulation of POMC processing in vitro. A) Experimental schematic for measuring the regulation POMC and its derivates by leptin or Furin inhibitor I, which blocks
prohormone convertases. B) Treatment with 25 uM Furin Inhibitor 1 (blue) signiﬁcantly reduced d-aMSH and b-MSH (P < 0.0001), and b-EP (P < 0.05) concentrations. C)
Treatment with recombinant human leptin signiﬁcantly increased the measured concentrations of d-aMSH, b-MSH, and b-EP at all concentrations tested. N ¼ 3 independent
experiments with 4e8 technical replicates per experiment. Error bars show SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
Original Article[7,65]. These ﬁndings have recently been challenged by a longer-term
study in which both a-MSH and d-a-MSH were genetically deleted
from mice, and then individually infused for 14 days into the mouse
brain over a range of concentrations. This study revealed that both
peptides could similarly reduce appetite and body weight in male mice
[6], and indeed d-a-MSH may be a more potent agonist of MC4R than
a-MSH [9]. We therefore suggest that, in humans, the relative
importance of both d-a-MSH and b-MSH may have been under-
estimated, and that the assumption that acetylated a-MSH is the
principal anorexigenic melanocortin peptide in humans should be
reconsidered.
In our studies, b-EP (1-31) was present at 2e4 fold higher concen-
trations than d-a-MSH or b-MSH in hPSC-derived neurons (Figure 4B),
in the human brain (Figure 4C), and upon induced secretion
(Figure 6B). Control experiments suggest that this observation was
likely not due to technical artefacts such as the degradation of standard
peptides. It is possible that b-EP (1-31) is intrinsically more stable
within the cell or more readily extracted by the methods we used.
However, it is also noteworthy that it only requires a single cleavage
event at Lys219-Arg220 (position 235-236 from translational start) to
be liberated from larger precursor peptides, whereas the generation of
either d-a-MSH or b-MSH requires at least two cleavage events. It is
also possible that POMC cleavage is less efﬁcient at the dibasic res-
idues ﬂanking a-MSH and b-MSH sequences than at Lys219-Arg220
due to steric or other reasons.
In addition to the well-characterised POMC-peptides a-MSH, d-a-
MSH, b-MSH and b-EP, we also identiﬁed g1-MSH [62] in one hPSC-
derived hypothalamic neuron sample. Like a-MSH, d-a-MSH and b-
MSH, the g-MSH peptide is anorexigenic [79] but in contrast to the
other MSH peptides it has higher afﬁnity for MC3R than MC4R [80,81].
Since g-MSH was not consistently detected, it may be present at low12 MOLECULAR METABOLISM- (2018) 1e16  2018 The Authors. Published by Elsevier Gconcentrations, possibly due to O-glycosylation at the asparagine
residue adjacent to its C-terminal dibasic cleavage site, which could
sterically interfere with peptide cleavage [82e85].
Predictions made by studying hypothalamic neurons derived from
three distinct hPSC lines were largely conﬁrmed in primary human
hypothalamic samples. However, the human brain contained a larger
repertoire of neuropeptides than we observed in vitro. Some of these
differences might be explained by the distinct anatomical origin of
neuropeptide-producing neurons, since our in vitro model generates
cells with a predominantly ventral hypothalamic regional identity [31],
whereas neurons producing gonadotropin releasing hormone (GNRH)
are generated in the olfactory placode and then migrate into the hy-
pothalamus [86], and neurons expressing glucagon like peptide 1
(GLP-1) project to the hypothalamus from nucleus of the solitary tract
(NTS) of the brainstem [87]. Other differences could be explained by
the maturation state of hPSC-derived hypothalamic neurons, which
might express some neuropeptides at levels below the detection limit
of the automated peptide identiﬁcation pipeline we employed. The use
of more sensitive LC-MS/MS instruments or the analysis of raw pep-
tidomic data using new discovery tools [88] may reveal further bio-
logically important peptides.
We found that POMC-derived peptides were robustly secreted upon
depolarisation of hPSC-derived hypothalamic neurons and that the
relative concentrations of b-MSH and b-EP were consistent with what
we observed in cell pellets (Figures 4B and 6B). However, the relative
ratio of secreted of d-a-MSH was unexpectedly low, less than half that
of b-MSH. This could be due to the instability of d-a-MSH in the su-
pernatant (though we did not detect many degradation products).
Alternatively, these data could suggest the differential vesicle pack-
aging and/or secretion efﬁciency of different POMC-derived peptides,
which has been previously reported in mice in vivo [89]. ThembH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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preferential release of POMC peptides with different physiological
functions could be an important mechanism for regulating feeding
behaviour in response to different physiological states.
Importantly, we found that exposure of hPSC-derived hypothalamic
neurons to leptin signiﬁcantly increased the concentration of d-a-MSH,
b-MSH and b-EP (Figure 7C). The mechanism for leptin elevating
POMC-derived peptide concentrations could be due to its previously
observed effects on inducing POMC transcription and translation
[26,28], its effects on promoting prohormone processing by increasing
PC1/3 and PC2 expression [29], or some combination of the two.
Conversely, treatment of cultures with a broad-spectrum PC inhibitor
that is likely to inhibit many PC enzymes at the concentration used
[90,91] signiﬁcantly reduced concentrations of POMC-derived pep-
tides. Together, these ﬁndings are consistent with observations made
in animals, suggesting that this human cellular model system may
have predictive power for understanding human-speciﬁc aspects of
POMC biology, such as the regulation of b-MSH processing and
secretion. The genetic or environmental manipulation of hPSC-derived
hypothalamic neurons coupled with quantitative LC-MS/MS-based
analysis may therefore provide insights into the molecular mecha-
nisms regulating neuronal responsiveness and neuropeptide pro-
cessing. The human-speciﬁc nature of several key ﬁndings in this
study highlight the need for further human cellular studies into the
central regulation of energy homeostasis, which has the potential to
identify novel therapeutic targets for obesity.
5. CONCLUSION
Quantitative LC-MS/MS of both primary and stem cell-derived human
hypothalamic neurons revealed that d-a-MSH and b-MSH are by far
the most abundant melanocortins, suggesting that the widely-held
assumption that a-MSH is the most important POMC-derived pep-
tide for regulating energy homeostasis should be revisited. The pro-
duction of human d-a-MSH, b-MSH and b-EP peptides is dynamically
regulated by leptin, establishing the utility of stem cell-derived hypo-
thalamic neurons for studying both POMC processing and neuronal
responsiveness to exogenous factors.
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